Bayer bets $547M on therapies for RNA-driven cancers Source: Seekingalpha
Browsing: Healthcare
Gain slips after early-stage data for Parkinson’s therapy Source: Seekingalpha
American Diversified to cancel 142M shares Source: Seekingalpha
BioCardia shares climb as it gets FDA clearance for its Morph DNA product family Source: Seekingalpha
Nuvectis gains on FDA’s orphan drug designation for cancer therapy Source: Seekingalpha
Neurocrine upped to overweight by Piper, sees ‘568 as still viable Source: Seekingalpha
CooperCompanies hits 52-week high on Q3 beat and guidance Source: Seekingalpha
Lifecore CFO John Morberg to depart, Ryan Lake to succeed Source: Seekingalpha
J&J submits FDA application for myasthenia gravis drug nipocalimab Source: Seekingalpha
Catalent ends FY24 on a strong note ahead of Novo buyout Source: Seekingalpha